{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:04:29Z","timestamp":1779710669546,"version":"3.53.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013840","name":"Biocenter Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013510","name":"Eye and Tissue Bank Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015735","name":"Helsinki Institute of Life Science, Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["1332770"],"award-info":[{"award-number":["1332770"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejps.2026.107507","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:59:11Z","timestamp":1773676751000},"page":"107507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The impact of active transport on rabbit corneal drug permeability: utilizing the microflow-based PermeaSys device"],"prefix":"10.1016","volume":"221","author":[{"given":"Eva","family":"Ramsay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati-Sisko","family":"Vellonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Tanhuanp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Ruponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Kallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6427-8042","authenticated-orcid":false,"given":"Heidi","family":"Kidron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107507_bib0001","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1152\/ajprenal.00402.2002","article-title":"Molecular characterization of human and rat organic anion transporter OATP-D","volume":"285","author":"Adachi","year":"2003","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejps.2026.107507_bib0002","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s13346-015-0275-6","article-title":"In vitro and ex vivo corneal penetration and absorption models","author":"Agarwal","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2026.107507_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0378-5173(87)90092-5","article-title":"Disposition of timolol and inulin in the rabbit eye following corneal versus non-corneal absorption","volume":"38","author":"Ahmed","year":"1987","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107507_bib0004","first-page":"584","article-title":"Importance of the noncorneal absorption route in topical ophthalmic drug delivery","volume":"26","author":"Ahmed","year":"1985","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2026.107507_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/02713680490504614","article-title":"Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium","volume":"29","author":"Anand","year":"2004","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejps.2026.107507_bib0006","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1089\/jop.2006.0095","article-title":"Expression of ABC-transporters in human corneal tissue and the transformed cell line, HCE-T","volume":"23","author":"Becker","year":"2007","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107507_bib0007","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0002-9394(74)90541-8","article-title":"Corneal permeation of topical pilocarpine nitrate in the rabbit","volume":"77","author":"Chrai","year":"1974","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2026.107507_bib0008","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/jpet.104.069583","article-title":"Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption","volume":"311","author":"Dey","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2026.107507_bib0009","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0002-9394(14)77735-9","article-title":"Penetration routes of topically applied eye medications","volume":"85","author":"Doane","year":"1978","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2026.107507_bib0010","series-title":"Topical Ocular Pharmacokinetics and Bioavailability For a Cocktail of atenolol, Timolol and Betaxolol in Rabbits","author":"Fayyaz","year":"2020"},{"key":"10.1016\/j.ejps.2026.107507_bib0011","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s11095-008-9741-x","article-title":"Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroids","volume":"26","author":"Hariharan","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107507_bib0012","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/jop.2009.0049","article-title":"Interaction of ocular hypotensive agents (PGF2 analogs - Bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea","volume":"25","author":"Hariharan","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107507_bib0013","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/2472630320916190","article-title":"Microflow-based device for In vitro and ex vivo drug permeability studies","volume":"25","author":"Hemmil\u00e4","year":"2020","journal-title":"SLAS. Technol."},{"key":"10.1016\/j.ejps.2026.107507_bib0014","first-page":"1194","article-title":"Identification of a Na + -dependent cationic and neutral","author":"Jain-Vakkalagadda","year":"2004","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107507_bib0015","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1167\/iovs.02-0907","article-title":"Identification and functional characterization of a Na+-independent large neutral amino acid transporter, LAT1, in human and rabbit cornea","volume":"44","author":"Jain-Vakkalagadda","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2026.107507_bib0016","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exer.2006.08.015","article-title":"Molecular evidence and functional expression of multidrug resistance associated protein (MRP) in rabbit corneal epithelial cells","volume":"84","author":"Karla","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejps.2026.107507_bib0017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2006.11.031","article-title":"Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux","volume":"336","author":"Karla","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107507_bib0018","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/jop.2008.0084","article-title":"Expression of multidrug resistance associated protein 5 (MRP5) on cornea and its role in drug efflux","volume":"25","author":"Karla","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107507_bib0019","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/02713680500306439","article-title":"Identification and characterization of a Na+-dependent neutral amino acid transporter, ASCT1, in rabbit corneal epithelial cell culture and rabbit cornea","volume":"30","author":"Katragadda","year":"2005","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejps.2026.107507_bib0020","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s11095-010-0132-8","article-title":"Prediction of the corneal permeability of drug-like compounds","volume":"27","author":"Kidron","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107507_bib0021","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/dmd.108.023200","article-title":"Transport of Diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug Transport by Diclofenac and Benzbromarone","volume":"37","author":"Lagas","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107507_bib0022","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1128\/AAC.01428-08","article-title":"Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: studies with ciprofloxacin-resistant cells","volume":"53","author":"Marquez","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2026.107507_bib0023","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/dmd.105.008219","article-title":"Breast cancer resistance protein (BCRP\/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion","volume":"34","author":"Merino","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107507_bib0024","doi-asserted-by":"crossref","unstructured":"Morrissey, K.M., Wen, C.C., Johns, S.J., Zhang, L., Huang, S.-M., Giacomini, K.M., 2012. The UCSF-FDA TransPortal: a public drug transporter database. 92, 545\u2013546.","DOI":"10.1038\/clpt.2012.44"},{"key":"10.1016\/j.ejps.2026.107507_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2023.123183","article-title":"Topical pharmacokinetics of brinzolamide suspensions in rabbits and variability analysis for sample size and design considerations","volume":"642","author":"Naageshwaran","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107507_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121515","article-title":"Topical pharmacokinetics of dexamethasone suspensions in the rabbit eye: bioavailability comparison","volume":"615","author":"Naageshwaran","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107507_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1753-5174.2010.00032.x","article-title":"Is Ciprofloxacin a substrate of P-glycoprotein?","volume":"4","author":"Park","year":"2011","journal-title":"Arch. Drug Inf."},{"key":"10.1016\/j.ejps.2026.107507_bib0028","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/dmd.111.039099","article-title":"Ocular pharmacokinetics of mapracorat, a novel, selective glucocorticoid receptor agonist, in rabbits and monkeys","volume":"39","author":"Proksch","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107507_bib0029","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","article-title":"Corneal and conjunctival drug permeability: systematic comparison and pharmacokinetic impact in the eye","volume":"119","author":"Ramsay","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107507_bib0030","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.3c01210","article-title":"Transporter protein expression of corneal epithelium in rabbit and porcine: evaluation of models for ocular drug transport study","author":"Ramsay","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107507_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107836","article-title":"Pharmacokinetics and intraocular pressure\u2013lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey","volume":"189","author":"Savinainen","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejps.2026.107507_bib0032","doi-asserted-by":"crossref","first-page":"22644","DOI":"10.1074\/jbc.M212399200","article-title":"ABCG2 Transports sulfated conjugates of steroids and xenobiotics","volume":"278","author":"Suzuki","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2026.107507_bib0033","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/108076803322660468","article-title":"Corneal and scleral permeability of quinolones\u2014a pharmacokinetics study","volume":"19","author":"Tai","year":"2003","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107507_bib0034","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.102.034330","article-title":"Characterization of methotrexate transport and its drug interactions with Human organic anion transporters","volume":"302","author":"Takeda","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2026.107507_bib0035","first-page":"2942","article-title":"Culture model of Human corneal epithelium for prediction of ocular drug absorption","volume":"42","author":"Toropainen","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2026.107507_bib0036","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107507_bib0037","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-5173(90)90215-P","article-title":"Controlled drug delivery devices for experimental ocular studies with timolol 2. Ocular and systemic absorption in rabbits","volume":"61","author":"Urtti","year":"1990","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107507_bib0038","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/dmd.108.024315","article-title":"Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of Human organic anion-transporting polypeptide 1B1 (SLCO1B1)","volume":"37","author":"van de Steeg","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107507_bib0039","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejps.2009.12.006","article-title":"Monocarboxylate transport in human corneal epithelium and cell lines","volume":"39","author":"Vellonen","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107507_bib0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.12.009","article-title":"Expression, activity and pharmacokinetic impact of ocular transporters","volume":"126","author":"Vellonen","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107507_bib0041","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1021\/mp400625z","article-title":"Expression in Human corneal cell culture models and animal corneal tissue","author":"Verstraelen","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107507_bib0042","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ijpharm.2012.10.007","article-title":"Expression analysis of MDR1, BCRP and MRP3 transporter proteins in different in vitro and ex vivo cornea models for drug absorption studies","volume":"441","author":"Verstraelen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107507_bib0043","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/02713689109001766","article-title":"Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration","volume":"10","author":"Wang","year":"1991","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejps.2026.107507_bib0044","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1124\/dmd.108.026286","article-title":"Characterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport","volume":"37","author":"Xiang","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107507_bib0045","first-page":"7225","article-title":"Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport","volume":"61","author":"Zeng","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2026.107507_bib0046","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/dmd.115.066944","article-title":"Diclofenac and its acyl glucuronide: determination of In vivovivo exposure in Human subjects and characterization as Human drug transporter substrates In vitro","volume":"44","author":"Zhang","year":"2016","journal-title":"Drug Metab. Dispos."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:50:39Z","timestamp":1779709839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726000813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"alternative-id":["S0928098726000813"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107507","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of active transport on rabbit corneal drug permeability: utilizing the microflow-based PermeaSys device","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107507"}}